DUBLIN, Dec 5, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Western Blotting Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) - Global Forecasts to 2021" report to their offering.
The western blotting market is expected to reach USD 730.7 Million in 2021 from USD 574.8 Million in 2016, growing at a CAGR of 4.9%.
Increasing number of research activities and R&D spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, growing proteomics market, growing number of industry-academic research collaborations, increasing demand for personalized medicine, and new product launches are expected to drive the growth of the market in the coming years.
The global market is segmented on the basis of product, application, and end user. By product, the market is categorized into consumables and instruments. The consumables segment is estimated to account for the largest share of the global market, by product in 2016. The western blotting instruments segment is segmented into gel electrophoresis instruments, blotting systems, and imagers. The blotting systems segment is expected to account for the largest share of the instruments market, by type in 2016 and is expected to grow at the highest CAGR during the forecast period (2016-2021). The western blotting consumables segment is further segmented into reagents, kits, and others (transfer membranes, blotting papers, primary & secondary antibodies, and gels, among others).
Based on the applications, the global western blotting market is segmented into biomedical & biochemical research, disease diagnostics, agriculture, and others (quality control and biologics). The biomedical & biochemical research segment is expected to account for the largest share of the global market, by application in 2016. However, the disease diagnostics segment is projected to grow at the highest CAGR from 2016 to 2021, owing to increasing diagnosis, incidences, and prevalence of HIV, HSV, HBV, Lyme disease, and mad cow's disease among others.
The western blotting market, by end user is segmented into academic & research institutes, pharmaceutical & biotechnology companies, diagnostic centers, and others (CROs, food & beverage companies, and forensic laboratories). The academic & research institutes segment is expected to command the largest share of the global market, by end user in 2016. However, the diagnostic centers segment is projected to grow at the highest CAGR from 2016 to 2021.
The report includes the study of key players offering western blotting such as:
- Advansta Inc.
- Bio-Rad Laboratories, Inc.
- Bio-Techne Corporation
- Cell Signaling Technology
- F. Hoffmann-La Roche Ltd.
- GE Healthcare
- Li-Cor Biosciences
- Merck Kgaa
- Perkinelmer, Inc.
- Thermo Fisher Scientific, Inc.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Global Western Blotting Market, By Product
7 Western Blotting Market, By Application
8 Western Blotting Market, By End User
9 Western Blotting Market, By Region
10 Competitive Landscape
11 Company Profiles
12 Appendix
For more information about this report visit http://www.researchandmarkets.com/research/h2wf34/western_blotting
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
